Similar articles for PMID: 10629033

Year	Number of Results
1992	1
1994	1
1995	2
1996	11
1997	6
1998	15
1999	11
2000	16
2001	13
2002	18
2003	8
2004	4
2007	1
2012	2
2024	0

1

p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines.

Aurelio ON, Kong XT, Gupta S, Stanbridge EJ. Aurelio ON, et al. Mol Cell Biol. 2000 Feb;20(3):770-8. doi: 10.1128/MCB.20.3.770-778.2000. Mol Cell Biol. 2000. PMID: 10629033 Free PMC article.

2

Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.

Kong XT, Gao H, Stanbridge EJ. Kong XT, et al. J Biol Chem. 2001 Aug 31;276(35):32990-3000. doi: 10.1074/jbc.M103681200. Epub 2001 Jun 6. J Biol Chem. 2001. PMID: 11395510 Free article.

3

Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.

Zacharatos PV, Gorgoulis VG, Kotsinas A, Manolis EN, Liloglou T, Rassidakis AN, Kanavaros P, Field JD, Halazonetis T, Kittas C. Zacharatos PV, et al. Anticancer Res. 1999 Jan-Feb;19(1A):579-87. Anticancer Res. 1999. PMID: 10226602

4

Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.

Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Ramirez PT, et al. Gynecol Oncol. 2001 Dec;83(3):543-8. doi: 10.1006/gyno.2001.6438. Gynecol Oncol. 2001. PMID: 11733969

5

Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.

Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, Fujimoto S, Fujinaga K. Kaneuchi M, et al. Mol Carcinog. 1999 Sep;26(1):44-52. Mol Carcinog. 1999. PMID: 10487521

6

p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.

Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G. Campomenosi P, et al. Oncogene. 2001 Jun 14;20(27):3573-9. doi: 10.1038/sj.onc.1204468. Oncogene. 2001. PMID: 11429705

7

Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.

Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D. Koutsodontis G, et al. J Biol Chem. 2001 Aug 3;276(31):29116-25. doi: 10.1074/jbc.M104130200. Epub 2001 May 30. J Biol Chem. 2001. PMID: 11384995 Free article.

8

A novel p53 mutant retained functional activity in lung carcinomas.

Ko JL, Chiao MC, Chang SL, Lin P, Lin JC, Sheu GT, Lee H. Ko JL, et al. DNA Repair (Amst). 2002 Sep 4;1(9):755-62. doi: 10.1016/s1568-7864(02)00094-0. DNA Repair (Amst). 2002. PMID: 12509279

9

Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.

Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Sun SY, et al. Cancer Res. 1999 Jun 15;59(12):2829-33. Cancer Res. 1999. PMID: 10383141

10

Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.

Inga A, Resnick MA. Inga A, et al. Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457. Oncogene. 2001. PMID: 11423991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

108 results

Results by year